Global Molecular biology enzyme is expected to reach $5.92 billion in 2020

Date: 2016-09-12

The global molecular biology enzymes market was valued at $3.82 billion in 2015, and is expected to grow at a CAGR of 10.32% to reach $5.92 billion in 2020.

The key drivers for this market are the rising R&D expenditure by the pharmaceutical and biotech companies, and increasing public funding for life science research. The World Health Organization estimates that the total aged population may rise from 605 million in 2000 (11% of the global population) to 2 billion by 2050, accounting for 22% of the global population. As this segment of the world population is more susceptible to chronic diseases, research into these ailments will become more significant, driving the growth of the molecular biology enzymes market.

Molecular biology enzymes find applications in a large number of fields in life science research. It also finds application in diagnostics and drug discovery research. These products are widely used for analysis of cell surface markers, which can act as diagnostics or therapeutic targets. 

PCR (polymerase chain reactions) is one of the most widely-used analytical and preparative techniques in molecular biology.

The enzymes segment is divided into ligases, phosphatases, polymerases, proteases and proteinases, restriction endonucleases, reverse transcriptase, and other enzymes.

Molecular biology enzymes classification market share:


Read Full Report:

Joanna | Executive – International Business and partner Relations
E-mail: | Tel: 001-510-400-8520


Contact With Us
Join templatemonster at google+
Customized Research
Request Sample